Drug Type Small molecule drug |
Synonyms 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)barbituric acid, 5-ethyl-5-isoamylbarbituric acid + [8] |
Target |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (20 Feb 1950), |
Regulation- |
Molecular FormulaC11H18N2NaO3 |
InChIKeyCGIPTVARALDUTG-UHFFFAOYSA-N |
CAS Registry64-43-7 |
Start Date01 Jun 2024 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00555 | Amobarbital sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Status Epilepticus | AU | 05 Sep 1991 | |
Sedation | JP | 20 Feb 1950 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |